SIGLEC15 and cancer: Next, we investigated the correlations between TUBA1C expression and the expression of immune checkpoints, including CD274, HAVCR2, CTLA4, LAG3, PDCD1LG2, PDCD1, SIGLEC15, and TIGIT, in cancers.